Article
Hepatitis C virus management: potential impact of nanotechnology.
Virology journal - 2 May 2017
Elberry Mostafa H, Darwish Noureldien H E, Mousa Shaker A
Abstract excerpt
Around 170-200 million individuals have hepatitis C virus (HCV), which represents ~ 3% of the world population, including ~ 3-5 million people in the USA. According to the WHO regional office in the Middle East, Egypt has the highest prevalence in the world, with 7% prevalence in adults. There had been no effective vaccine for HCV; a combination of PEG-Interferon and ribavirin for at least 48 weeks was the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.